Geron reported $3.42M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Bio Techne USD 981K 84K Mar/2026
Cassava Sciences USD 1.17M 47K Sep/2025
Cytokinetics USD 11.02M 448K Mar/2026
Exelixis USD 14.21M 1.92M Jun/2026
Genmab DKK 14M 11M Mar/2026
Geron USD 3.42M 624K Mar/2026
Gilead Sciences USD 95M 0 Mar/2026
Incyte USD 38.12M 4.43M Jun/2026
MacroGenics USD 1.55M 26K Mar/2026
Novavax USD 303K 27K Dec/2021